IBM (IBM) Stock Forecast & Price Target

IBM is attractive fundamentally because its business mix is increasingly anchored by recurring software revenue, with roughly 75% of the business in software and about 50% recurring overall, helping support durable cash generation. Recent operating trends also strengthen the case: software grew 9% CC, infrastructure rose 5% versus consensus, and free cash flow guidance was raised to grow more than $1B year over year as adjusted EBITDA improves. The company’s hybrid cloud, AI, and consulting franchises, led by Red Hat, watsonx, and mainframes, give it multiple growth levers, while its relationships with 95% of Fortune 500 companies support continued cross-sell and resilience.

IBM is viewed negatively because its software growth assumptions appear to require an increasingly aggressive acceleration, with 2027 consensus implying cc organic software growth rising from 3.9% to 5.5% on a two-year stack and from 2.6% to 6.8% organically. The outlook depends heavily on management extracting $2.2bn in Hashi/Confluent synergies and monetizing the z17 mainframe cycle, yet that looks optimistic without another acquisition and is vulnerable to execution risk. Persistent competition from next-gen entrants, customer churn, weak retention, and limited flexibility as a mature company raise the odds of slower growth and share loss in consulting and software.